Symptom Management Note (Non-Pain Symptoms)

Encounter Date/Time: [Date; Time] | Patient: [Identifiers per local policy] | Setting: [inpatient / outpatient / home / telehealth] | Author: [Name, credentials, service] | Visit Type: [initial / return / urgent] | Information Sources: [patient / caregiver / nursing / chart review] (Note interpreter use if applicable) | Code Status: [Code status] (Only include if directly relevant to symptom management decisions) | Primary Diagnosis & Treatment Context: [Disease and current/recent therapies] (Only include if directly relevant to today's symptom decisions)

Chief Concern and Clinical Context

[Primary symptom concern(s) in 1–2 sentences with optional brief patient quote and clinician framing]

• [Current disease status and recent treatments impacting symptoms or medication choices]
• [Pertinent comorbidities affecting medication risk: respiratory disease, QT-prolongation risk, renal/hepatic dysfunction, cognitive impairment, fall risk]
• [Current route and access constraints: oral tolerance, feeding tube, IV/SC availability]
• [Relevant allergies/intolerances or prior adverse effects] (Only include if present)
• [Care environment or caregiving considerations affecting implementation] (Only include if relevant)

Subjective

Symptom Scores Summary (Use validated tool if available: ESAS-r, IPOS, or other. Do not infer scores; if not obtained, document "not obtained" or specify proxy/observational method.)

• [Symptom 1]: [Severity 0–10 or categorical]; [timeframe: now / past 24h / past week]; [trend: improved / stable / worsened / no prior]; [source: patient self-report / proxy by caregiver / nursing observation]
• [Symptom 2]: [Severity and details as above] (List only symptoms addressed today; if not assessed, write "not assessed")

[Symptom Name] HPI

[Focused HPI including: severity and trajectory with onset and pattern; triggers and alleviating factors; associated symptoms pertinent to differential; functional impact on sleep, eating, ambulation, conversation, caregiver burden; prior and current regimen with response, PRN frequency, effectiveness, adverse effects; patient priorities regarding comfort-alertness trade-offs] (Repeat this subsection for each symptom addressed. If cognition impaired, note collateral source and reliability.)

Objective

• Vitals: [RR; SpO2 with O2 status; HR; BP; Temp; Weight if appetite/cachexia addressed] (Include only those relevant to symptoms addressed)
• Focused Exam: [General appearance/distress; work of breathing and auscultation; volume status; mental status/attention/agitation level as relevant] (Note when exam is limited and why)
• Pertinent Data Reviewed: [Labs, imaging, EKG as relevant to reversible-cause evaluation or medication safety]
• Current Symptom-Related Medications: [Medication list with dose/route/frequency; route feasibility; adherence concerns]
• PRN Usage: [Agent; doses over timeframe; effectiveness; adverse effects] (From MAR or caregiver report; important when considering titration)

Assessment

(Problem-oriented list in descending order of urgency/distress)

[Symptom/Problem #1]: [One-line severity summary]

• [Most likely contributors] (Label as clinical inference)
• [Key supporting/ruling-out findings]
• [Response to current management: responding / partial / refractory / unclear]

[Symptom/Problem #2]: [One-line severity summary]

(Repeat for each symptom addressed)

Plan

[Symptom/Problem #1]

• Symptom Goal: [Patient-centered target]
• Reversible Contributors: [To treat now; to investigate; deferred and rationale]
• Nonpharmacologic: [Specific measures recommended/performed; caregiver education provided]
• Pharmacologic Plan:
  • [Continue / Stop / Start / Titrate]: [medication; dose; route; frequency] — [Indication/target symptom]
  • Titration instructions: [What to change; when; based on which response metric or side effect]
  • Monitoring: [Efficacy indicators; toxicity/safety indicators; when to hold or escalate]
  • Safety considerations: [Drug interactions; falls; respiratory depression; QT prolongation; delirium risk] (Only include if relevant)
  • [Comfort-alertness trade-off discussion] (Include if sedating medications considered)
• Monitoring Strategy: [Reassessment interval and method; thresholds for regimen change or escalation; side-effect surveillance]

[Symptom/Problem #2]

(Repeat structure above for each additional symptom addressed)

Coordination, Education, and Safety Net

• Patient/Caregiver Education: [PRN use and scheduling; sedating medication precautions; symptom management strategies]
• Safety Guidance: [Fall precautions; driving restrictions; aspiration precautions] (Include only if relevant)
• Warning Signs: [When to call/return: worsening dyspnea at rest; inability to take medications; escalating agitation; new confusion; concerning sedation]
• Follow-up: [Timing; modality; contingency plan if symptoms worsen before follow-up]
• Care Coordination: [Consults/referrals; communication with other teams; medication access issues] (Only include if applicable)

Time-Based Billing Attestation: [Total minutes; activities performed] (Include only if billing by time)

(Global rules: Only document negatives actually assessed. If information is missing, omit or state "not assessed today." Do not infer patient-reported severity scores, code status, adherence, capacity, or presence of hallucinations—these require explicit source documentation. Label clinical inferences as such.)